Irrational medication prescribing and paucity of glycated hemoglobin testing in resourcelimited settings leads to poor health outcomes in patients with type 2 diabetes mellitus This study aims to describe prescription pattern and assess glycaemic control using Glycated hemoglobin among type 2 diabetic patients attending clinic at Abubakar Tafawa Balewa University Teaching Hospital. Bauchi, Nigeria. A 6 months prospective, cross sectional, observational survey, conducted in 200 patients with uncontrolled type 2 diabetes mellitus (≥ 7mmol/L fasting blood glucose). Prescribed medications and sociodemographic characteristics were obtained through faceto-face interview, body mass index was computed using weight and height measurements and 4μl sample of capillary blood obtained from finger prick of individual subject was used for Glycated haemoglobin test. Data was analysed using SPSS version 20.0 and results were expressed in descriptive and inferential statistics. A total of 200 type 2 diabetic patients, with uncontrolled glycaemia participated in the study. Majority were ≥ 40 years (82.5%), female (67.5%), married (86.5%) and engaged in low level of physical activity (81%). About half had no formal education (47%) and 51.5% had family history of diabetes. (Metformin was the most commonly prescribed antidiabetes agents (91.5%), while only 5.5% of the study population received antilipidaemic medication. Furthermore, chi square analysis showed that no factor was associated with uncontrolled glycaemia using Glycated haemoglobin test (P > 0.05). Insufficient prescribing of antilipidaemic agents was observed and about half (46%) of the participants had controlled glycaemia using Glycated haemoglobin test as against 100% using fasting glucose test. Interprofessional Collaborative care, involving physicians, pharmacists, patients and other health care providers, as well as point-of-care Glycated haemoglobin testing are recommended to ensure rational medication prescribing and improved care outcomes.

Keywords : Prescription Pattern, Antidiabetes, Glycated Haemoglobin, Type 2 Diabetes, Nigeria